"Akutn\u00ED kardiogenn\u00ED po\u0161kozen\u00ED jater a levosimendan" . "Ludka, Ond\u0159ej" . . . "Akutn\u00ED kardiogenn\u00ED po\u0161kozen\u00ED jater a levosimendan"@cs . . "RIV/65269705:_____/13:#0002178!RIV14-MZ0-65269705" . "15" . "Akutn\u00ED kardiogenn\u00ED po\u0161kozen\u00ED jater a levosimendan" . . "CZ - \u010Cesk\u00E1 republika" . "Kardiologick\u00E1 revue" . "levosimendan; cardiohepatic failure; acute cardiac liver injury"@en . . . "Acute cardiac liver injury and levosimendan"@en . . "Acute cardiac liver injury and levosimendan. Heart failure is the major public health problem of the 21st century, with frequent re-hospitalizations, impaired quality of life and prognosis. The progression of heart failure is often characterized by an increasing inability of the heart to meet the metabolic demands of most organs. While the consequences of acute heart failure on renal function have been described many times, a comprehensive description of the impact of acute heart failure on the liver function is still lacking. In the treatment of acute heart failure, we can exploit the hepatoprotective effect of levosimendan, which is probably due to its favorable hemodynamic effects, specifically because of its positive inotropic and vasodilatory effects, together with a direct hepatocytic effect, accompanied by an increase in metabolic and adaptation reserves of hepatocytes.."@en . "Acute cardiac liver injury and levosimendan"@en . . "Srde\u010Dn\u00ED selh\u00E1n\u00ED pat\u0159\u00ED mezi z\u00E1va\u017En\u00E9 zdravotn\u00ED probl\u00E9my 21. stolet\u00ED vedouc\u00ED zejm\u00E9na k \u010Dast\u00FDm rehospitalizac\u00EDm, sni\u017Euje t\u00E9\u017E kvalitu \u017Eivota a zhor\u0161uje progn\u00F3zu nemocn\u00FDch. P\u0159i progresi chronick\u00E9ho srde\u010Dn\u00EDho selh\u00E1n\u00ED doch\u00E1z\u00ED \u010Dasto k nar\u016Fstaj\u00EDc\u00ED neschopnosti srdce spl\u0148ovat metabolick\u00E9 n\u00E1roky v\u011Bt\u0161iny org\u00E1n\u016F. Zat\u00EDmco d\u016Fsledky akutn\u00EDho srde\u010Dn\u00EDho selh\u00E1n\u00ED na ren\u00E1ln\u00ED funkce byly v literatu\u0159e mnohokr\u00E1t pops\u00E1ny, komplexn\u00ED popis dopadu akutn\u00EDho srde\u010Dn\u00EDho selh\u00E1n\u00ED na jatern\u00ED funkce v literatu\u0159e st\u00E1le chyb\u00ED. V l\u00E9\u010Db\u011B akutn\u00EDho srde\u010Dn\u00EDho selh\u00E1n\u00ED m\u016F\u017Eeme vyu\u017E\u00EDt hepatoprotektivn\u00ED \u00FA\u010Dinek levosimendanu, kter\u00FD spo\u010D\u00EDv\u00E1 pravd\u011Bpodobn\u011B v jeho p\u0159\u00EDzniv\u00E9m hemodynamick\u00E9m p\u016Fsoben\u00ED podm\u00EDn\u011Bn\u00E9m jeho specificky pozitivn\u011B inotropn\u00EDm a vazodilata\u010Dn\u00EDm efektem spole\u010Dn\u011B s p\u0159\u00EDm\u00FDm hepatocyt\u00E1rn\u00EDm p\u016Fsoben\u00EDm se zv\u00FD\u0161en\u00EDm metabolick\u00FDch a adapta\u010Dn\u00EDch rezerv hepatocytu." . . "3"^^ . . . . "1212-4540" . "3"^^ . . "[AA0B92A4FB7C]" . . . "RIV/65269705:_____/13:#0002178" . "4" . . "\u0160pinar, Jind\u0159ich" . "Akutn\u00ED kardiogenn\u00ED po\u0161kozen\u00ED jater a levosimendan"@cs . "4"^^ . "Hl\u00E1sensk\u00FD, Ji\u0159\u00ED" . "59980" . "I" . "Srde\u010Dn\u00ED selh\u00E1n\u00ED pat\u0159\u00ED mezi z\u00E1va\u017En\u00E9 zdravotn\u00ED probl\u00E9my 21. stolet\u00ED vedouc\u00ED zejm\u00E9na k \u010Dast\u00FDm rehospitalizac\u00EDm, sni\u017Euje t\u00E9\u017E kvalitu \u017Eivota a zhor\u0161uje progn\u00F3zu nemocn\u00FDch. P\u0159i progresi chronick\u00E9ho srde\u010Dn\u00EDho selh\u00E1n\u00ED doch\u00E1z\u00ED \u010Dasto k nar\u016Fstaj\u00EDc\u00ED neschopnosti srdce spl\u0148ovat metabolick\u00E9 n\u00E1roky v\u011Bt\u0161iny org\u00E1n\u016F. Zat\u00EDmco d\u016Fsledky akutn\u00EDho srde\u010Dn\u00EDho selh\u00E1n\u00ED na ren\u00E1ln\u00ED funkce byly v literatu\u0159e mnohokr\u00E1t pops\u00E1ny, komplexn\u00ED popis dopadu akutn\u00EDho srde\u010Dn\u00EDho selh\u00E1n\u00ED na jatern\u00ED funkce v literatu\u0159e st\u00E1le chyb\u00ED. V l\u00E9\u010Db\u011B akutn\u00EDho srde\u010Dn\u00EDho selh\u00E1n\u00ED m\u016F\u017Eeme vyu\u017E\u00EDt hepatoprotektivn\u00ED \u00FA\u010Dinek levosimendanu, kter\u00FD spo\u010D\u00EDv\u00E1 pravd\u011Bpodobn\u011B v jeho p\u0159\u00EDzniv\u00E9m hemodynamick\u00E9m p\u016Fsoben\u00ED podm\u00EDn\u011Bn\u00E9m jeho specificky pozitivn\u011B inotropn\u00EDm a vazodilata\u010Dn\u00EDm efektem spole\u010Dn\u011B s p\u0159\u00EDm\u00FDm hepatocyt\u00E1rn\u00EDm p\u016Fsoben\u00EDm se zv\u00FD\u0161en\u00EDm metabolick\u00FDch a adapta\u010Dn\u00EDch rezerv hepatocytu."@cs . .